![[Weekly funding roundup May 24-30] Capital inflow continues to remain steady](https://images.yourstory.com/cs/2/220356402d6d11e9aa979329348d4c3e/Weekly-funding-1741961216560.jpg)
2 Beaten-Down Stocks to Buy on the Dip
It won't come as a surprise to anyone to hear that quite a few quality stocks have performed terribly this year. Some have encountered company-specific problems, others have been swept up in the market's volatility, and for others still, it's a combination of the two.While broader equities may remain unpredictable in the short term, now might be as good a time as any to pick up shares of top companies on the dip. Novo Nordisk (NYSE: NVO) and Cava Group (NYSE: CAVA) are excellent choices.Novo Nordisk's shares have significantly lagged the market in the past year due to a series of issues. The Denmark-based drugmaker faced significant clinical setbacks while its main competitor in the market for diabetes and obesity medicines, Eli Lilly, continued to record critical clinical wins.Continue reading
It won't come as a surprise to anyone to hear that quite a few quality stocks have performed terribly this year. Some have encountered company-specific problems, others have been swept up in the market's volatility, and for others still, it's a combination of the two.
While broader equities may remain unpredictable in the short term, now might be as good a time as any to pick up shares of top companies on the dip. Novo Nordisk (NYSE: NVO) and Cava Group (NYSE: CAVA) are excellent choices.
Novo Nordisk's shares have significantly lagged the market in the past year due to a series of issues. The Denmark-based drugmaker faced significant clinical setbacks while its main competitor in the market for diabetes and obesity medicines, Eli Lilly, continued to record critical clinical wins.
